Drug Topics

NOVEMBER 16, 2023

VAERS was designed to collect reports of symptoms, diagnoses, hospital admissions, and deaths after vaccination for postmarket safety signals.

Vaccines 187

Vaccines Hospitals 187

Pharmacy Times

NOVEMBER 16, 2023

The study also found that 82% of the surveyed physicians reported not getting labs to help determine treatment options for their patients.

149

149

STAT

NOVEMBER 16, 2023

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new phase of genetic medicine.   The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise.

145

145

Pharmacy Times

NOVEMBER 16, 2023

In addition to language barriers, pharmacy translation software errors may cause further complications when filling patient prescriptions.

149

149

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

NOVEMBER 16, 2023

A dangerous decline in the rate of children vaccinated against measles is spurring a global increase in cases and deaths from the highly contagious virus, according to a report released Thursday. Estimated measles cases rose 18% to 9 million in 2022 when compared to the previous year, and deaths rose by 43% to 136,200, according to the report , jointly authored by the World Health Organization and the Centers for Disease Control and Prevention.

Vaccines 145

Vaccines 145

Pharmacy Times

NOVEMBER 16, 2023

While manganese can sometimes be considered toxic, prenatal exposure may be linked to better memory at adolescence.

145

145

Drug Topics

NOVEMBER 16, 2023

In a population of 1191 patients with early-stage breast cancer, 20.7% of patients with a vitamin D deficiency experienced grade 3 or higher sensoryCIPN.

144

144

STAT

NOVEMBER 16, 2023

History just happened. For the first time, a regulator has cleared a treatment using CRISPR , the gene-editing technology, for patients. The regulator is the United Kingdom’s Medicines and Healthcare products Regulatory Agency. The product is Casgevy, a treatment for sickle cell disease and beta thalassemia, two blood disorders. It was developed by CRISPR Therapeutics, the Swiss company co-founded by Nobel laureate Emmanuelle Charpentier, and Vertex Pharmaceuticals, a large Boston-based b

145

145

Pharmacy Times

NOVEMBER 16, 2023

This interstate agreement can empower pharmacists to respond to large-scale emergencies

139

139

STAT

NOVEMBER 16, 2023

In 1993, I published “Listening to Prozac,” a book that grew out of my clinical experience prescribing what was then a new class of medications, ones thought to moderate depression through their effect on the way that the brain handles the neurotransmitter serotonin. Some of my patients had reported marked favorable reactions to the drugs — first Prozac and, soon after, Zoloft.

141

141

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

NOVEMBER 16, 2023

The approval marks the first authorized at-home sample collection test for sexually transmitted diseases.

FDA 139

FDA 139

STAT

NOVEMBER 16, 2023

Three months ago, my aunt Margaret had a stroke. Days before, she was repainting her bathroom and driving herself. Now, she needs help with dressing and getting in and out of bed, and our family is grappling with the fact that this fiercely self-sufficient woman will never live independently again. This health crisis has been compounded at every turn by failures of the health care system — failures that are particularly infuriating to me because I have devoted my life to solving these ver

Compounding 138

Compounding Insurance 138

Pharmacy Times

NOVEMBER 16, 2023

Expert discusses changes health care professionals should know about drug coverage and out-of-pocket costs through the IRA

131

131

STAT

NOVEMBER 16, 2023

Dr. Reddy’s Laboratories, one of the world’s largest generic drugmakers, was cited by the U.S. Food and Drug Administration for a host of manufacturing violations at one of its plants in India, the latest instance in which the company was tagged by the regulator for quality-control problems. In a recent inspection report , the agency found several notable failures, such as major production equipment that was not appropriately cleaned; a quality-control unit that did not investigate

FDA 136

FDA 136

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

NOVEMBER 16, 2023

Micron nets nearly $24M from Gates Foundation to pioneer needle-free vaccine tech in low- and middle-income countries fkansteiner Thu, 11/16/2023 - 11:08

Vaccines 130

Vaccines 130

STAT

NOVEMBER 16, 2023

More than a tenth of fecal immunochemical tests, used for routine colorectal cancer screening, contained samples that could not be processed by labs, according to a study published this week in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research. This is over twice the amount recommended by the U.S.

131

131

Fierce Pharma

NOVEMBER 16, 2023

Watch out, Pfizer and Roche. Thanks to an acquisition and now an FDA approval, Bristol Myers Squibb is entering a niche lung cancer market. | Watch out, Pfizer and Roche. Thanks to an acquisition and now an FDA approval, Bristol Myers Squibb is entering a niche lung cancer market.

FDA 128

FDA 128

STAT

NOVEMBER 16, 2023

The Food and Drug Administration on Wednesday approved a new treatment for people with non-small cell lung cancer that contains a rare genetic alteration called Ros1. The genetically targeted medicine, called Augtyro, will be sold by Bristol Myers Squibb. It was developed by a small biotech company, Turning Point Therapeutics, that was acquired by Bristol in June 2022.

127

127

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

NOVEMBER 16, 2023

The products include Crovalimab, Dapagliflozin, Secukinumab, Roflumilast

127

127

Fierce Pharma

NOVEMBER 16, 2023

Timothy Yap, Ph.D., used to see patients nearing the end of their cancer journey in his phase 1 department at the University of Texas' MD Anderson Cancer Center. | Cancer drugs are getting better thanks to innovation, driven by the data and regulatory forces like Project FrontRunner.

126

126

STAT

NOVEMBER 16, 2023

Advances in  childhood cancer  are a success story in modern medicine. But in the past decade, those strides have stalled for Black and Hispanic youth, opening a gap in death rates, according to a new report published Thursday. Childhood cancers are rare and treatments have improved drastically in recent decades, saving lives.

124

124

Fierce Pharma

NOVEMBER 16, 2023

Vertex, CRISPR gain 'historic' nod in UK for exa-cel. But will cost watchdogs embrace the gene-editing therapy?

124

124

Pharmacy Times

NOVEMBER 16, 2023

The RESCUE BT2 trial sheds further light on the agent’s potential.

123

123

Drug Topics

NOVEMBER 16, 2023

An analysis on the Diabetes Prevention Program in England found it was effective at improving key cardiovascular risk factors, including glycated hemoglobin and excess body weight.

123

123

Fierce Healthcare

NOVEMBER 16, 2023

Another international survey has painted Americans’ access to care in a poor light when compared to those living in other wealthy countries, particularly when looking at disparities in residents’ i | Nearly half of surveyed U.S. adults with average or lower incomes said they had a cost-related reason for skipping medical care during the prior 12 months, versus 29% of those with higher incomes.

122

122

PharmaVoice

NOVEMBER 16, 2023

Dr. Paul Moss, a hematology expert in the U.K., conducted a study with AstraZeneca showing the alarming extent to which immunocompromised patients are burdened with COVID-19.

116

116

Fierce Healthcare

NOVEMBER 16, 2023

Beginning in 2025, health plans sold in state-run insurance exchanges would be required to meet time and distance standards that are at least as adequate as mandated on federal marketplaces, accord | State insurance exchanges would be required to meet the same standards as federal exchanges under a new rule by CMS on Wednesday.

Insurance 119

Insurance 119

The Checkup by Singlecare

NOVEMBER 16, 2023

When you have a bacterial infection, like strep throat or a urinary tract infection, an antibiotic is often the solution to the problem. The antibiotic eliminates the bacteria causing your symptoms. With a tooth infection, also known as a dental abscess or abscessed tooth, you may need an antibiotic and an additional procedure—depending on how severe the situation is.

Immunization 115

Immunization 115

Fierce Healthcare

NOVEMBER 16, 2023

Mayo Clinic pulled in $302 million of operating income (6.8% operating margin) during the third quarter, raising the organization’s year-to-date up to $751 million (5.7% operating margin), accordin | A rock-solid 6.8% operating margin for the quarter came courtesy of continued strong demand, stabilizing workforce issues and a focus on performance improvement, leadership said.

Mayo Clinic 116

Mayo Clinic 116

pharmaphorum

NOVEMBER 16, 2023

Life sciences inspections and investigations Mike.

115

115

Fierce Healthcare

NOVEMBER 16, 2023

Value-based care leads to a better patient experience — and a better experience for physicians, too, a new study from Humana shows.

116

116

pharmaphorum

NOVEMBER 16, 2023

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Venu Mallarapu, vice president of global strategy and operations at eClinical Solutions, about the ins and outs of successful AI implementation within pharma and healthcare.

115

115

European Pharmaceutical Review

NOVEMBER 16, 2023

Casgevy (exagamglogene autotemcel), also known as exa-cel, is the first treatment to be licensed that uses CRISPR. It has been conditionally authorised by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a gene-editing therapy for certain patients 12 years old and over with sickle-cell disease and transfusion-dependent β-thalassemia.

114

114